Format

Send to

Choose Destination
Kidney Int. 2014 Mar;85(3):499-501. doi: 10.1038/ki.2013.549.

Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?

Author information

1
Mount Sinai School of Medicine, New York, New York, USA.

Abstract

A soluble proteinuric substance has been postulated as a cause of primary focal segmental glomerulosclerosis (FSGS), and one candidate soluble urokinase receptor (suPAR). Evaluation of published results shows that serum suPAR determinations by current methodology do not reliably distinguish FSGS from other proteinuric glomerular diseases and serum suPAR cannot currently be considered a valid biomarker for primary or secondary FSGS. However, this should not discourage further research on potential roles of suPAR in proteinuric renal disease, including FSGS.

PMID:
24583981
DOI:
10.1038/ki.2013.549
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center